Longevity of Non-Rechargeable Implantable Pulse Generators in Deep Brain Stimulation: A Systematic Review
Stereotactic and Functional Neurosurgery · 14.11.2026
DOI: 10.1159/sfn/aeuag020 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Stereotactic and Functional Neurosurgery, online erschienen am 14.11.2026. Verfasst von Mohammad Mofatteh und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The longevity of non-rechargeable implantable pulse generator (IPG) is an important consideration in deep brain stimulation (DBS), as battery depletion may cause loss of therapeutic benefit, and repeated replacement exposes patients to cumulative surgical morbidity. We aimed to systematically evaluate non-rechargeable DBS IPG longevity, determinants of battery life, comparative device performance, and clinical consequences of battery depletion and replacement.
Methods
PubMed, Scopus, and Web of Science were searched from inception to 2 August 2026. Original human studies reporting non-rechargeable IPG longevity, depletion or replacement, energy consumption, or related clinical outcomes were included; rechargeable IPGs were considered separately.
Results
Of 1,476 initial records, 30 studies were included, with reported sample sizes totalling 4,101 observations. Observed non-rechargeable IPG longevity ranged from approximately 2 to >6 years. In a single cohort stratified by indication, longevity was shortest in dystonia (37.0±2.0 months), intermediate in Parkinson’s disease (51.5±2.3 months), and longest in essential tremor (71.9±6.7 months), although disease, target, and stimulation requirements were closely interrelated. Higher stimulation-energy demand, including greater amplitude, pulse width, frequency, and total electrical energy delivered (TEED), was consistently associated with shorter longevity. Direct comparisons also demonstrated clinically important differences in longevity between generations of non-rechargeable IPGs, independent of stimulation-energy demand in some cohorts. Major infection occurred after 30 replacements (2.3%), and each previous replacement increased infection odds (OR 1.6). Depletion-associated parkinsonism-hyperpyrexia syndrome resulted in 2 deaths. Overall, 18 studies (60.0%) had a high risk of bias.
Conclusion
DBS IPG longevity reflects an interaction between stimulation-energy requirements, programming strategy, device architecture, and clinical context. Energy-efficient programming, proactive battery surveillance, and individualized device selection may reduce replacement burden while maintaining effective stimulation. Prospective studies of contemporary IPGs using standardized longevity endpoints are needed to validate and expand these findings.
Autor:innen und Institutionen
ORCID-Profile: Mohammad Mofatteh, Keyoumars Ashkan
Zitieren
APA
Mofatteh, M., & Ashkan, K. (2026). Longevity of Non-Rechargeable Implantable Pulse Generators in Deep Brain Stimulation: A Systematic Review. Stereotactic and Functional Neurosurgery. https://doi.org/10.1159/sfn/aeuag020
Vancouver
Mofatteh M, Ashkan K. Longevity of Non-Rechargeable Implantable Pulse Generators in Deep Brain Stimulation: A Systematic Review. Stereotactic and Functional Neurosurgery. 2026. doi:10.1159/sfn/aeuag020
BibTeX
@article{Mofatteh2026,
author = {Mofatteh, Mohammad and Ashkan, Keyoumars},
title = {Longevity of Non-Rechargeable Implantable Pulse Generators in Deep Brain Stimulation: A Systematic Review},
journal = {Stereotactic and Functional Neurosurgery},
year = {2026},
doi = {10.1159/sfn/aeuag020}
}
EUVIMED